Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topic search: NEUROLOGY

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

 
Refine your search by entering keywords here:

Neurology Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
Rofiq Hanifah Mohd
, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023
Pg. 512-521

Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet
Hazdi Siti Nursaqifah
, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023
Pg. 522-527

Ipratropium Bromide 0.05% Nasal Spray
Allen Loyd V Jr
Sep/Oct 2023
Pg. 418-419

Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
Jul/Aug 2023
Pg. 317-318

Lamotrigine 1 mg/mL in SuspendIt Plus
Allen Loyd V Jr
Jul/Aug 2023
Pg. 323

Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
Jul/Aug 2023
Pg. 329

Chemical Stability of Epinephrine 10 mcg/mL Diluted in 0.9% Sodium Chloride and Stored in Polypropylene Syringes at 4 degrees C and 25 degrees C
Hook Roxanne
, Neault Ashleigh, Scharrer Devan, Law Shirley, Walker Scott E, Ma Nathan H, Riss Vera
Jul/Aug 2023
Pg. 347-351

Migraine Headache Suppositories
Allen Loyd V Jr
May/Jun 2023
Pg. 237

Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90%
Allen Loyd V Jr
Mar/Apr 2023
Pg. 145

Pilocarpine Hydrochloride 0.3% w/v Solution
Allen Loyd V Jr
Mar/Apr 2023
Pg. 149-151

Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 51

Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
Sep/Oct 2022
Pg. 431

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 235

Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 237

Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2022
Pg. 239

The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren
, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022
Pg. 110-115

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
Mar/Apr 2022
Pg. 141

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 145

Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
Mar/Apr 2022
Pg. 146

Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 147

Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 148

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
Nov/Dec 2021
Pg. 504

Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 505

Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
Nov/Dec 2021
Pg. 506

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 414

Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417

Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 418

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation
Odanaka Keita
, Kojima Hiroki, Nakagawa Naoto
May/Jun 2021
Pg. 258-262

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

Doxepin Hydrochloride 5% in Cetaphil Cream
Allen Loyd V Jr
Jul/Aug 2020
Pg. 314

Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
Jul/Aug 2020
Pg. 319

Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
Jul/Aug 2020
Pg. 320

Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 321

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III
, Everett Eric, Chamberlain Tyler
May/Jun 2020
Pg. 194-197

Baclofen 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 224

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
May/Jun 2020
Pg. 233

Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley
, Patel Jalpa
May/Jun 2020
Pg. 242-245

Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
Mar/Apr 2020
Pg. 104-108

Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 130

Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Mar/Apr 2020
Pg. 132

Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 138

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
Allen Loyd V Jr
Jan/Feb 2020
Pg. 56

Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
Jan/Feb 2020
Pg. 62

Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
Jan/Feb 2020
Pg. 63

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 486

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 495

Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah
, Agu Remigius U
Nov/Dec 2019
Pg. 496-503

Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George
, Daleo Charles, Batson SL
Sep/Oct 2019
Pg. 358-364

Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
Jul/Aug 2019
Pg. 317

Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
Jul/Aug 2019
Pg. 318

Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin
, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2019
Pg. 320-323

Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 234

Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
May/Jun 2019
Pg. 236

An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability
Reindel Kristin L
, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
May/Jun 2019
Pg. 258-263

Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
Mar/Apr 2019
Pg. 94-104

Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
Mar/Apr 2019
Pg. 106-111

Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
Mar/Apr 2019
Pg. 113-119

Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2019
Pg. 151

Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Mar/Apr 2019
Pg. 157-162

Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure
Ip Kendice
, Banov Daniel, Bassani Gus, Morgan Latisha
Mar/Apr 2019
Pg. 167-175

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah
, Agu Remigius U
Jan/Feb 2019
Pg. 82-87

Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 492

Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh
, Baltzley Sarah, AlGhananeem Abeer
Nov/Dec 2018
Pg. 498-503

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2018
Pg. 409

Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
Sep/Oct 2018
Pg. 410

Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
Jul/Aug 2018
Pg. 321

Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 325

Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin
, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
Jul/Aug 2018
Pg. 335-339

Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 235

Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O
, Zdoryk Oleksandr A
May/Jun 2018
Pg. 240-246

Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
Mar/Apr 2018
Pg. 146

Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 148

Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 149

Prochlorperazine Edisylate 0.5% Nasal Spray
Allen Loyd V Jr
Mar/Apr 2018
Pg. 150

Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J
, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Mar/Apr 2018
Pg. 172-175

Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2018
Pg. 56

Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 58

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George
, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018
Pg. 76-85

Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George
, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Jan/Feb 2018
Pg. 86-94

Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2017
Pg. 409

Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 411

Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen
, Hohlfelder Benjamin, Szumita Paul M
Sep/Oct 2017
Pg. 436-439

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2017
Pg. 318

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Meloxicam 1% Topical Gel
Allen Loyd V Jr
May/Jun 2017
Pg. 235

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 65

Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H
, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016
Pg. 461-467

Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
Nov/Dec 2016
Pg. 506

Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2016
Pg. 509

Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 512

Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph
, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016
Pg. 517-520

Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2016
Pg. 406

Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2016
Pg. 409

Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2016
Pg. 318

Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 326

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M
, Collin Michael
May/Jun 2016
Pg. 197-201

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 235

Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky
, Shah Samit, Patel Jaymin, Thomas Michael C
May/Jun 2016
Pg. 236-238

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Blue Goo Anti-Itch Gel
Allen Loyd V Jr
Mar/Apr 2016
Pg. 144

Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
Mar/Apr 2016
Pg. 147

Aprepitant 80-mg Capsules
Allen Loyd V Jr
Jan/Feb 2016
Pg. 48

Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
Jan/Feb 2016
Pg. 49

Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
Nov/Dec 2015
Pg. 507

Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
Nov/Dec 2015
Pg. 510

Memantine Hydrochloride Capsules
Allen Loyd V Jr
Nov/Dec 2015
Pg. 511

Atropine Sulfate 1% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 242

Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
May/Jun 2015
Pg. 244

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 246

Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 247

Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles
Dewulf Joseph
, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
May/Jun 2015
Pg. 268-270

Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 149

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 150

Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan
, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015
Pg. 161-166

Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie
, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015
Pg. 167-173

Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
Jan/Feb 2015
Pg. 67

Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 69

Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 495

Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 496

Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 501

Tamsulosin Hydrochloride 0.2-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 503

Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan
, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014
Pg. 504-511

Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 411

Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2014
Pg. 414

Sumatriptan Succinate 12-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 416

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
Jul/Aug 2014
Pg. 322

Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 330

Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
Jul/Aug 2014
Pg. 345-347

Dibucaine 1% Ointment
Allen Loyd V Jr
May/Jun 2014
Pg. 236

Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2014
Pg. 239

Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 241

Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
May/Jun 2014
Pg. 253-255

Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Allen Loyd V Jr
Mar/Apr 2014
Pg. 142

Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 144

Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 147

Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Weeks Phillip A
, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
Mar/Apr 2014
Pg. 152-158

Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
Jan/Feb 2014
Pg. 14-19

Neostigmine Bromide 15-mg Capsules
Allen Loyd V Jr
Jan/Feb 2014
Pg. 64

Phenobarbital 60-mg Capsules
Allen Loyd V Jr
Jan/Feb 2014
Pg. 66

Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 498

Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 503

Metyrosine 250-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 506

Phenytoin Sodium 50-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 507

Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 418

Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 422

Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 423

Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 335

Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013
Pg. 344-346

Reserpine 0.5-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 237

Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
Mar/Apr 2013
Pg. 113-123

Alcohol Dehydrated Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 145

Betahistine 16-mg Capsules
Allen Loyd V Jr
Mar/Apr 2013
Pg. 146

Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 65

Granisetron 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 66

Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 68

Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 70

Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 500

Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 505

Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
Nov/Dec 2012
Pg. 506

Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 507

Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 508

Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 509

Stability of Propranolol Hydrochloride in SyrSpend SF
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 513-515

Medical Therapy for Acquired Urinary Incontinence in Dogs
Hill Katie
, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
Sep/Oct 2012
Pg. 369-375

Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 422

Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 424

Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 427

A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A
, Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274

Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
Jul/Aug 2012
Pg. 276-286

Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 334

Etomidate 2-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 335

Methyldopate Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 338

Stability of Gabapentin in SyrSpend SF
Sorenson Bridget
, Voudrie Mark A II, Gehrig Dan
Jul/Aug 2012
Pg. 347-349

A Concise Discussion of Headache Types, Part 2: Migraine
Williams LaVonn A
May/Jun 2012
Pg. 182-188

Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
May/Jun 2012
Pg. 196-205

Acetazolamide 100-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 238

Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 244

Orphenadrine Citrate 30-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 245

Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 246

Midazolam 5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 162

Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 163

A Concise Discussion of Headache Types, Part 1
Williams LaVonn A
Mar/Apr 2012
Pg. 125-132

Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 156

Glycopyrrolate 0.2-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 159

Labetalol Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 160

Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 161

Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method
Zhang Yang
, Jiang Hongliang, Hutson Paul
Mar/Apr 2012
Pg. 170-173

Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Zhang Yang
, Scarlett Cameron, Hutson Paul
Jan/Feb 2012
Pg. 82-85

Calculations
Stockton Shelly J
Jan/Feb 2012
Pg. 69

Magnesium Sulfate 10% Injection (0.8 mEq/mL)
Allen Loyd V Jr
Jan/Feb 2012
Pg. 72

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
Sep/Oct 2011
Pg. 386-387

Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 419

Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 420

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
Jul/Aug 2011
Pg. 316-319

Glycopyrrolate 0.5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 337

Riboflavin 5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 343

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 242

Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2011
Pg. 246

Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 245

Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
Mar/Apr 2011
Pg. 156

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 157

Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes
McCluskey Susan V
, Lovely Jenna K
Mar/Apr 2011
Pg. 170-173

Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos
, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011
Pg. 27-31

Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Elder Deborah Lester
, Zheng Bo, White Catherine A, Li Dawei
Jan/Feb 2011
Pg. 74-77

Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F
, Wong Keith, Goddard Rob, Johanson Christel
Jan/Feb 2011
Pg. 81-84

Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 512

Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 513

Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 514

Bromazepam 2.5-mg/mL Drops
Allen Loyd V Jr
Nov/Dec 2010
Pg. 515

Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 426

Fenoldopam Mesylate Injection
Allen Loyd V Jr
Jul/Aug 2010
Pg. 340

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 243

Lamotrigine 25-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2010
Pg. 156

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F
, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010
Pg. 21-25

Trigger Point Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 75

Sleepless in America: Compounding with Melatonin
Wynn Tom
, Rawlings Kate
Jan/Feb 2010
Pg. 10-13

Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
Nov/Dec 2009
Pg. 498-505

The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J
, Asbill Scott
Nov/Dec 2009
Pg. 569-571

Topiramate 6-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2009
Pg. 560

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Parish Roy C
Nov/Dec 2009
Pg. 572-573

Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2009
Pg. 437

Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Gupta Vishnu D
Sep/Oct 2009
Pg. 438-439

Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms
Gupta Vishnu D
Sep/Oct 2009
Pg. 445-446

Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
Jul/Aug 2009
Pg. 340

Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Update on Managing Neuropathic Pain
McNulty Jack P
, Muller George
May/Jun 2009
Pg. 182-190

Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules
Allen Loyd V Jr
May/Jun 2009
Pg. 246

Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules
Allen Loyd V Jr
May/Jun 2009
Pg. 249

Tolterodine 2-mg/5-mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2009
Pg. 160

Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
Sep/Oct 2008
Pg. 398-401

Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties
Donnelly Ronald F
, Corman Celine
Nov/Dec 2008
Pg. 550-552

The Magic of Magnesium
Boomsma Diane
Jul/Aug 2008
Pg. 306-309

Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A
, Mead Jay H
Jul/Aug 2008
Pg. 310-315

Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2008
Pg. 368-371

Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2008
Pg. 267

Chemical Stability of Naltrexone Hydrochloride Injection
Gupta Vishnu D
May/Jun 2008
Pg. 274-275

Topical Treatment of Neuropathic Pain
Vadaurri Vince
May/Jun 2008
Pg. 182-190

Acyclovir 5% Topical Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 146

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Carbamazepine Topical Preparations
Allen Loyd V Jr
Mar/Apr 2008
Pg. 150

Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J
, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Jan/Feb 2008
Pg. 83-85

Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2007
Pg. 520-524

Equine Cushing's Disease: A Clinical Update
Bliss George
Sep/Oct 2007
Pg. 384-388

Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Allen Loyd V Jr
Sep/Oct 2007
Pg. 422

Levorphanol for Excruciating Pain from Oral Cancer: A Case Report
McNulty Jack P
May/Jun 2007
Pg. 212-218

Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 245

Isoproterenol Compound Elixir
Allen Loyd V Jr
May/Jun 2007
Pg. 246

Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 249

Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla
, Wynn Tom
May/Jun 2007
Pg. 181-184

Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
May/Jun 2007
Pg. 187-192

Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
May/Jun 2007
Pg. 200

Levorphanol for the Treatment of Severe Chronic Pain
McNulty Jack P
May/Jun 2007
Pg. 202-211

Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
Mar/Apr 2007
Pg. 116-120

Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
Mar/Apr 2007
Pg. 131

Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2007
Pg. 160

Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
Jan/Feb 2007
Pg. 26-27

Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 70

Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 73

Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 75

Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
Nov/Dec 2006
Pg. 434-435

Gabapentin 100-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 456

Migraine: A General Approach to Prevention and Treatment
Kennedy Bonnie M
Sep/Oct 2006
Pg. 344-350

Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
Sep/Oct 2006
Pg. 351

Midazolam Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 387

Nitrazepam 1-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 388

Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A
, Zhang Yanping, Koontz Susannah E
Sep/Oct 2006
Pg. 396-399

Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 299

Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 304

Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free
Gupta Vishnu D
Jul/Aug 2006
Pg. 318-319

Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong Weeranuj
, Teixeira M Glaucia, Mayer Gabriele E
Jul/Aug 2006
Pg. 316-317

Carvedilol 1.25-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2006
Pg. 220

Lamotrigine 1-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2006
Pg. 223

Mexiletine Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2006
Pg. 225

PostScription: Treatment of Chronic Pain with Methadone or Levorphanol
McNulty Jack P
Mar/Apr 2006
Pg. 159-160

Hospice from a Compounding Pharmacist's Perspective
Jones Marty
Mar/Apr 2006
Pg. 89-93

Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 66

Alprazolam 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 472

Clonazepam 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 474

Dolasetron 10-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 475

Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Gupta Vishnu D
Nov/Dec 2005
Pg. 484-486

PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
Nov/Dec 2005
Pg. 487-488

Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain
Mishkan Emilyn S
Sep/Oct 2005
Pg. 339-346

Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain
Allen Loyd V Jr
Sep/Oct 2005
Pg. 349-352

Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration
Landry Christine
, Forest Jean-Marc, Hildgen Patrice
Sep/Oct 2005
Pg. 396-298

Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A
, Xu Quanyun A
May/Jun 2005
Pg. 235-237

Amitriptyline Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2005
Pg. 62

Gabapentin 2-mg/mL Injection, Preservative Free
Allen Loyd V Jr
Jan/Feb 2005
Pg. 64

Guaifenesin 50-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2005
Pg. 65

Phenol 8% Injection
Allen Loyd V Jr
Jan/Feb 2005
Pg. 69

Return to Top